EC Healthcare (2138.HK)
HKD 0.7
(-1.41%)
HKD 0.7
(-1.41%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 597.44 Million HKD | 9.35% |
| 2022 | 548.65 Million HKD | 30.01% |
| 2021 | 421.99 Million HKD | 26.89% |
| 2020 | 332.56 Million HKD | 8.3% |
| 2019 | 307.08 Million HKD | -42.68% |
| 2018 | 535.7 Million HKD | 37.65% |
| 2017 | 389.18 Million HKD | 56.31% |
| 2016 | 248.98 Million HKD | 19.03% |
| 2015 | 209.17 Million HKD | 37.27% |
| 2014 | 152.38 Million HKD | 3.09% |
| 2013 | 147.81 Million HKD | 54.9% |
| 2012 | 95.42 Million HKD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q4 | 298.95 Million HKD | -0.02% |
| 2023 Q2 | 299.02 Million HKD | 9.39% |
| 2023 FY | 599.95 Million HKD | 9.35% |
| 2022 FY | 548.65 Million HKD | 30.01% |
| 2022 Q4 | 273.35 Million HKD | -0.71% |
| 2022 Q2 | 275.3 Million HKD | 38.92% |
| 2021 Q2 | 225.83 Million HKD | 30.66% |
| 2021 Q4 | 198.17 Million HKD | -12.25% |
| 2021 FY | 421.99 Million HKD | 26.89% |
| 2020 FY | 332.56 Million HKD | 8.3% |
| 2020 Q4 | 172.83 Million HKD | 15.83% |
| 2020 Q2 | 149.2 Million HKD | 35.91% |
| 2019 Q4 | 109.78 Million HKD | -44.4% |
| 2019 Q2 | 197.44 Million HKD | -27.14% |
| 2019 FY | 307.08 Million HKD | -42.68% |
| 2018 FY | 535.7 Million HKD | 37.65% |
| 2018 Q2 | 264.71 Million HKD | 25.87% |
| 2018 Q4 | 270.98 Million HKD | 2.37% |
| 2017 Q4 | 210.3 Million HKD | 17.57% |
| 2017 FY | 389.18 Million HKD | 56.31% |
| 2017 Q2 | 178.87 Million HKD | 36.88% |
| 2016 FY | 248.98 Million HKD | 19.03% |
| 2016 Q2 | 118.29 Million HKD | 2.5% |
| 2016 Q4 | 130.68 Million HKD | 10.47% |
| 2015 FY | 209.17 Million HKD | 37.27% |
| 2015 Q4 | 115.41 Million HKD | 23.09% |
| 2015 Q2 | 93.76 Million HKD | 8.7% |
| 2014 Q2 | 66.13 Million HKD | 0.0% |
| 2014 FY | 152.38 Million HKD | 3.09% |
| 2014 Q4 | 86.25 Million HKD | 30.43% |
| 2013 FY | 147.81 Million HKD | 54.9% |
| 2012 FY | 95.42 Million HKD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 204.08 Million HKD | -192.748% |
| Innovative Pharmaceutical Biotech Limited | 14.27 Million HKD | -4085.568% |
| China Overseas Nuoxin International Holdings Limited | 38.32 Million HKD | -1458.818% |
| Prosperous Future Holdings Limited | 118.15 Million HKD | -405.665% |
| Huasheng International Holding Limited | 153.46 Million HKD | -289.311% |
| Fourace Industries Group Holdings Limited | 57.65 Million HKD | -936.229% |
| Evergreen Products Group Limited | 152.17 Million HKD | -292.616% |
| Ming Fai International Holdings Limited | 357.68 Million HKD | -67.034% |
| Blue Moon Group Holdings Limited | 4.4 Billion HKD | 86.452% |
| SuperRobotics Holdings Limited | 15.16 Million HKD | -3840.69% |
| Takbo Group Holdings Limited | 65.71 Million HKD | -809.109% |
| Hyfusin Group Holdings Limited | 196.91 Million HKD | -203.412% |